Bioscience Animal Health Valuation

Q: What is the Fair Price of BIS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

BIS (THB3.7) is trading above our estimate of [[fair value]] (THB0.47)

Is BIS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BIS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BIS (THB3.7) is trading above our estimate of fair value (THB0.47)

Significantly Below Fair Value: BIS is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BIS?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for BIS. This is calculated by dividing BIS's market cap by their current preferred multiple.
What is BIS's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

BIS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.5x
Enterprise Value/EBITDA	11.5x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does BIS's PE Ratio compare to its peers?

The above table shows the PE ratio for BIS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	25.9x
WINMED Winnergy Medical	32.1x	n/a	฿816.0m
SEI SEI Medical	37.7x	32.5%	฿1.0b
SMD SaintMed	22.7x	n/a	฿851.6m
BIZ Business Alignment	11.1x	n/a	฿2.0b
BIS Bioscience Animal Health	18.8x	n/a	฿1.2b

Price-To-Earnings vs Peers: BIS is good value based on its Price-To-Earnings Ratio (18.8x) compared to the peer average (25.9x).

Price to Earnings Ratio vs Industry

How does BIS's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	10.6%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	10.6%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: BIS is good value based on its Price-To-Earnings Ratio (18.8x) compared to the TH Healthcare industry average (22.7x).

Price to Earnings Ratio vs Fair Ratio

What is BIS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BIS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	18.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BIS's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.